Rejoinder

Ji L McShane LM Krailo M , et al. Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial. Clin Trials IN PRESS.

Saville BR Muerer W . Commentary on Ji et al: sub-optimal illustration of response adaptive randomization. Clin Trials IN PRESS.

Berry DA. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 107–109.

Buyse M. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 119–121.

Du Y Wang X JackLee J. Simulation study for evaluating the performance of response-adaptive randomization. Contemp Clin Trials 2015; 40: 15–25.

Freidlin B Korn EL Gray R , et al. Multi-arm clinical trials of new agents: some design considerations. Clin Cancer Res 2008; 14(14): 4368–4371.

Freidlin B McShane LM Polley MY , et al. Randomized phase II trial designs with biomarkers. J Clin Oncol 2012; 30(26): 3304–3309.

Freidlin B Korn EL. Adaptive randomization versus interim monitoring. J Clin Oncol 2013; 31(7): 969–970.

Hey SP Kimmelman J. Are outcome-adaptive allocation trials ethical. Clin Trials 2015; 12(2): 102–106.

Hey SP Kimmelman J. Rejoinder. Clin Trials 2015; 12(2): 125–127.

Joffe S Ellenberg SS. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 116–118.

Korn EL Freidlin B. Outcome —adaptive randomization: is it useful. J Clin Oncol 2011; 29(6): 771–776.

Korn EL Freidlin B. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 122–124.

Korn EL Freidlin B. Adaptive clinical trials: advantages and disadvantages of various adaptive design elements. J Natl Cancer Inst 2017; 109(6). DOI: 10.1093/jnci/djx013.

Lee JJ Chen N Yin G. Worth adapting? Revisiting the usefulness of outcome-adaptive randomization. Clin Cancer Res 2012; 18(17): 4498–4507.

Lee JJ Xuemin G Suyu Liu . Bayesian adaptive randomization designs for targeted agent development. Clin Trials 2010; 7(5): 584–596.

Lee JJ. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 110–112.

Saxman SB. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 113–115.

Thall PF Wathen JK. Practical Bayesian adaptive randomisation in clinical trials. Eur J Cancer 2007; 43(5): 859–866.

Thall PF Fox P Wathen JK . Some caveats for outcome adaptive randomization in clinical trials. In: Sverdlov O (ed.) Modern adaptive randomized clinical trials: statistical and practical aspects. Boca Raton, FL: Chapman & Hall/CRC, 2015, pp. 287–305.

Yuan Y Yin G. On the usefulness of outcome-adaptive randomization. J Clin Oncol 2011; 29(13): e390–e392; author reply e393.